Distinctive patterns of DNA methylation associated with Parkinson disease: Identification of concordant epigenetic changes in brain and peripheral blood leukocytes

Epigenetics

Volumn 8, Issue 10, 2013, Pages 1030-1038

  Masliah, Eliezer ^a   Dumaop, Wilmar ^a   Galasko, Douglas ^a   Desplats, Paula ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; DNA methylation; Epigenetics; Genome wide methylation; Neurodegeneration; Parkinson disease; Peripheral blood leukocytes

Indexed keywords

BIOLOGICAL MARKER; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; ENTACAPONE; MEMANTINE; RASAGILINE; RIVASTIGMINE; SELEGILINE;

AGE; AGED; ARTICLE; BOOTSTRAPPING; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DNA METHYLATION; DNA MICROARRAY; DRUG EFFECT; EPIGENETICS; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE; MALE; METHYLATION SENSITIVE RESTRICTION POLYMERASE CHAIN REACTION; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; PARKINSON DISEASE; POLYMERASE CHAIN REACTION;

BRAIN; DNA METHYLATION; EPIGENETICS; GENOME-WIDE METHYLATION; NEURODEGENERATION; PARKINSON DISEASE; PERIPHERAL BLOOD LEUKOCYTES;

BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LEUKOCYTES; MALE; PARKINSON DISEASE;

EID: 84884920554     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.25865     Document Type: Article

References (53)

1. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003; 39: 889-909; PMID: 12971891; http://dx. doi. org/10. 1016/S0896-6273(03)00568-3
2. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839-40; PMID: 9278044; http://dx. doi. org/10. 1038/42166
3. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Abnormal accumulation of NACP/alphasynuclein in neurodegenerative disorders. Am J Pathol 1998; 152: 367-72; PMID: 9466562
4. Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009; 14: 478-500; PMID: 19165601; http://dx. doi. org/10. 1007/s10495-008-0309-3
5. Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, et al. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain 2009; 132: 1795-809; PMID: 19052140; http://dx. doi. org/10. 1093/brain/awn323
6. Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, et al. Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiol Dis 2008; 29: 515-28; PMID: 18191405; http://dx. doi. org/10. 1016/j. nbd. 2007. 11. 008
7. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, et al. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 2011; 14: 1345-51; PMID: 21874013; http://dx. doi. org/10. 1038/nn. 2900
8. Day JJ, Sweatt JD. DNA methylation and memory formation. Nat Neurosci 2010; 13: 1319-23; PMID: 20975755; http://dx. doi. org/10. 1038/nn. 2666
9. Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009; 8: 1056-72; PMID: 19833297; http://dx. doi. org/10. 1016/S1474-4422(09)70262-5
10. Desplats P, Spencer B, Coffee E, Patel P, Michael S, Patrick C, et al. Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J Biol Chem 2011; 286: 9031-7; PMID: 21296890; http://dx. doi. org/10. 1074/jbc. C110. 212589
11. Jowaed A, Schmitt I, Kaut O, Wüllner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 2010; 30: 6355-9; PMID: 20445061; http://dx. doi. org/10. 1523/JNEUROSCI. 6119-09. 2010
12. Matsumoto L, Takuma H, Tamaoka A, Kurisaki H, Date H, Tsuji T, et al. CpG Demethylation Enhances Apha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease. PLoS ONE 2010; 5: 1-9; http://dx. doi. org/10. 1371/journal. pone. 0015522
13. Graeber MB. Biomarkers for Parkinson's disease. Exp Neurol 2009; 216: 249-53; PMID: 19166835; http://dx. doi. org/10. 1016/j. expneurol. 2008. 12. 017
14. Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, et al. Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 2005; 11: 6505-11; PMID: 16166426; http://dx. doi. org/10. 1158/1078-0432. CCR-05-0625
15. He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He YS, et al. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet 2010; 202: 1-10; PMID: 20804913; http://dx. doi. org/10. 1016/j. cancergencyto. 2010. 05. 018
16. Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, et al. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2004; 22: 2363-70; PMID: 15197197; http://dx. doi. org/10. 1200/JCO. 2004. 10. 077
17. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13: 679-92; PMID: 22945394; http://dx. doi. org/10. 1038/nrg3270
18. Jain K. The Handbook of Biomarkers. Humana Press 2010.
19. Burn DJ. Cortical Lewy body disease and Parkinson's disease dementia. Curr Opin Neurol 2006; 19: 572-9; PMID: 17102696; http://dx. doi. org/10. 1097/01. wco. 0000247607. 34697. a2
20. Lee SH, Kim SS, Tae WS, Lee SY, Lee KU, Jhoo J. Brain volumetry in Parkinson's disease with and without dementia: where are the differences? Acta Radiol 2013; PMID: 23474765; http://dx. doi. org/10. 1177/0284185113476029
21. Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2013; 84: 875-82; PMID: 23463873; http://dx. doi. org/10. 1136/jnnp-2012-304126
22. Adalsteinsson BT, Gudnason H, Aspelund T, Harris TB, Launer LJ, Eiriksdottir G, et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One 2012; 7: e46705; PMID: 23071618; http://dx. doi. org/10. 1371/journal. pone. 0046705
23. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7: e41361; PMID: 22848472; http://dx. doi. org/10. 1371/journal. pone. 0041361
24. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13: R43; PMID: 22703893; http://dx. doi. org/10. 1186/gb-2012-13-6-r43
25. Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 2013; 41(Database issue): D377-86; PMID: 23193289; http://dx. doi. org/10. 1093/nar/gks1118
26. Nakamura T, Cho DH, Lipton SA. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Exp Neurol 2012; 238: 12-21; PMID: 22771760; http://dx. doi. org/10. 1016/j. expneurol. 2012. 06. 032
27. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98: 288-95; PMID: 21839163; http://dx. doi. org/10. 1016/j. ygeno. 2011. 07. 007
28. Kibriya MG, Raza M, Jasmine F, Roy S, Paul-Brutus R, Rahaman R, et al. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med Genomics 2011; 4: 50; PMID: 21699707; http://dx. doi. org/10. 1186/1755-8794-4-50
29. Naumova OY, Lee M, Koposov R, Szyf M, Dozier M, Grigorenko EL. Differential patterns of wholegenome DNA methylation in institutionalized children and children raised by their biological parents. Dev Psychopathol 2012; 24: 143-55; PMID: 22123582; http://dx. doi. org/10. 1017/S0954579411000605
30. Efron BaT. R. An Introduction to the Bootstrap. Monographs on Statistics and Applied Probability 1993; 57: 1-399
31. Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, Flynn J, et al. Ontology-based metaanalysis of global collections of high-throughput public data. PLoS One 2010; 5: 5; PMID: 20927376; http://dx. doi. org/10. 1371/journal. pone. 0013066
32. Desplats P, Patel P, Kosberg K, Mante M, Patrick C, Rockenstein E, et al. Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson's disease. Mol Neurodegener 2012; 7: 49; PMID: 23017109; http://dx. doi. org/10. 1186/1750-1326-7-49
33. Jakovcevski M, Bharadwaj R, Straubhaar J, Gao G, Gavin DP, Jakovcevski I, et al. Prefrontal Cortical Dysfunction After Overexpression of Histone Deacetylase 1. Biol Psychiatry 2013; PMID: 23664640; http://dx. doi. org/10. 1016/j. biopsych. 2013. 03. 020
34. Miñones-Moyano E, Friedländer MR, Pallares J, Kagerbauer B, Porta S, Escaramís G, et al. Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction. RNA Biol 2013; 10: 10; PMID: 23673382; http://dx. doi. org/10. 4161/rna. 24813
35. Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, et al. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol 2012; 13: R97; PMID: 23034122; http://dx. doi. org/10. 1186/gb-2012-13-10-r97
36. Kumaran R, van der Brug M, Vandrovcova J, Ding J, Sharma S, Renton A, Dillman A, Lees A, Cookson MR, Bandopadhyay R. Gene expression changes across multiple regions of the Parkinson's disease brain. Gene Expression Omnibus (GEO) NCBI 2011: Series GSE28894.
37. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 2006; 7: 1-11; PMID: 16344956; http://dx. doi. org/10. 1007/s10048-005-0020-2
38. Roth R. Human body index-transcriptional profiling. Gene Expression Omnibus (GEO) NCBI 2007: Series GSE7307.
39. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, et al.; Global PD Gene Expression (GPEX) Consortium. PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2010; 2: 52ra73; PMID: 20926834; http://dx. doi. org/10. 1126/scitranslmed. 3001059
40. Durrenberger PF, Grünblatt E, Fernando FS, Monoranu CM, Evans J, Riederer P, et al. Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study. Parkinsons Dis 2012; 2012: 214714; PMID: 22548201
41. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007; 3: e98; PMID: 17571925; http://dx. doi. org/10. 1371/journal. pgen. 0030098
42. Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, Rockenstein E, et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A 2010; 107: 16970-5; PMID: 20837543; http://dx. doi. org/10. 1073/pnas. 1011751107
43. Muller KE, LaVange L. M., Ramey, S. L. and Ramey, C. T. Power calculations for general multivariate models including repeated measures applications. J Am Stat Assoc 1992; 87: 1209-26; http://dx. doi. org/10. 1080/01 621459. 1992. 10476281
44. Zhang Y, James M, Middleton FA, Davis RL. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 2005; 137B: 5-16; PMID: 15965975; http://dx. doi. org/10. 1002/ajmg. b. 30195
45. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009; 130: 234-9; PMID: 19150625; http://dx. doi. org/10. 1016/j. mad. 2008. 12. 003
46. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001; 10: 687-92; PMID: 11257100; http://dx. doi. org/10. 1093/hmg/10. 7. 687
47. Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res 2012; 22: 407-19; PMID: 21613409; http://dx. doi. org/10. 1101/gr. 119867. 110
48. Benjamini YaHY. Controlling the False Discovery Rate: A Practical and Powerful Approch to Multiple Testing. J R Stat Soc Ser A Stat Soc 1995; 57: 289-300
49. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011; 7: e1002141; PMID: 21738487; http://dx. doi. org/10. 1371/journal. pgen. 1002141
50. Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010; 74: 97-109; PMID: 20070850; http://dx. doi. org/10. 1111/j. 1469-1809. 2009. 00560. x
51. Spencer CC, Plagnol V, Strange A, Gardner M, Paisan-Ruiz C, Band G, et al.; UK Parkinson's Disease Consortium; Wellcome Trust Case Control Consortium 2. Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 2011; 20: 345-53; PMID: 21044948; http://dx. doi. org/10. 1093/hmg/ddq469
52. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, et al. Impact of inflammation on epigenetic DNA methylation-a novel risk factor for cardiovascular disease? J Intern Med 2007; 261: 488-99; PMID: 17444888; http://dx. doi. org/10. 1111/j. 1365-2796. 2007. 01777. x
53. Eisenhart C. The assumptions underlying the analysis of variance. Biometrics 1947; 3: 1-21; PMID: 20240414; http://dx. doi. org/10. 2307/3001534